Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (1)
  • Antioxidant
    (1)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Cholinesterase (ChE)
    (1)
  • NO Synthase
    (1)
  • Others
    (1)
TargetMol | Tags By Natures
  • Zingiber
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
  • Immune System
    (1)
  • Infection
    (1)
  • Inflammation
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

22608-11-3

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Natural Products
    2
    TargetMol | Natural_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
  • Demethoxycurcumin (Standard)
    TMSM-266522608-11-3
    Demethoxycurcumin (Standard) is a reference standard for research and analysis in studies involving Demethoxycurcumin. 1. Demethoxycurcumin (Desmethoxycurcumin) has antioxidant activity. 2. Demethoxycurcumin has anti-inflammatory activity. 3. Demethoxycurcumin has anti-proliferative activity. 4. Demethoxycurcumin has anti-acanthamoebic effect. 5. Demethoxycurcumin is a potential additive natural product in combination with chemotherapeutic agents in drug-resistant cancers. 6. Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells.
    • $216
    7-10 days
    Size
    QTY
  • Demethoxycurcumin
    Monodemethoxycurcumin, Desmethoxycurcumin, Curcumin II
    T6S168322608-11-3
    1. Demethoxycurcumin (Desmethoxycurcumin) has antioxidant activity. 2. Demethoxycurcumin has anti-inflammatory activity. 3. Demethoxycurcumin has anti-proliferative activity. 4. Demethoxycurcumin has anti-acanthamoebic effect. 5. Demethoxycurcumin is a potential additive natural product in combination with chemotherapeutic agents in drug-resistant cancers. 6. Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells.
    • $37
    In Stock
    Size
    QTY